Announcing Request for Proposals from the
Johns Hopkins ALACRITY Center
Concept paper due: 2/25/19
The Johns Hopkins ALACRITY Center for Health and
Longevity in Mental Illness, funded by a NIMH P50, is pleased to announce
Requests for Proposals for our 2019 Pilot Grant Program on topics related
to improving physical health and addressing premature mortality for
persons with serious mental illness.
Johns Hopkins doctoral fellows and faculty at
all levels are welcome to apply and can request funding for 1-2 years
up to $50,000 per year. Concept notes are due 2/25/19.
For more information, please see the full RFP
and on our website.
Please contact us with questions at email@example.com.
Area Lyme Foundation Emerging Leader Award Grant Program
Application deadline: March
The Bay Area Lyme Foundation Emerging Leader Awards
(ELA) recognize researchers bringing new approaches and creative thinking
to the field of Lyme disease. These grants support new and innovative
projects and aim to attract aspiring new scientific talent to the field
of Lyme. Candidate applications must include a viable proposal for a
proof-of-concept project to be funded, in part or in sum, by the grant
award. This year, the organization will offer two $100,000 grants to
researchers in academia or the private sector form the post-doctoral
level through the assistant professor, or equivalent.
Applicants for each award must have:
- A defined approach to improved diagnostics
or therapies for Lyme disease
- An affiliation with a US academic or research
institution, or corporate equivalent
- Demonstrated professional and scientific leadership
in biological and medical sciences
- Exhibited scientific curiosity and an established
pattern of creative thinking
Full criteria and an application can be
found at https://www.bayarealyme.org/
our-research/emerging-leader-award/. Potential applicants with questions
should contact firstname.lastname@example.org.
Johns Hopkins University | Emerson Collective Cancer Research Fund Request
Application deadline: March 11, 2019
The Emerson Collective
is proud to announce another round of funding for cancer research at
Johns Hopkins University. Johns Hopkins University | Emerson Collective
Cancer Research Fund is requesting individual or team proposals for
research projects related, but not limited to, immunotherapy, metabolic
therapies, early detection advancements, 'high risk/high reward' initiatives
and/or -omic approaches cancer and drug development. Positive criteria
include the potential of a project to significantly impact our understanding
of and/or approaches to the prevention, diagnosis, or treatment of cancer.
This RFP is open to all faculty undertaking research relevant to cancer
at Johns Hopkins. A team of Johns Hopkins | Emerson Collective Cancer
Research Fund employees and associates will evaluate the applicant pool.
Applicants will be
evaluated on the following positive criteria:
- The audacity and innovation of the research
proposal. Incremental research will not be funded.
- The potential of the proposed research to affect
multiple cancer types
- The potential to translate said research into
further experiments, and clinical trials
- The applicant's lack of resources to pursue
the proposed research
- Compliance with a two-year maximum timeframe
for research The applicant's prior experimental track record will
not be the principal determining factor in evaluation.
- RFP Launch: Monday, January 7, 2019
- Proposals Due: Monday, March 11, 2019 5 p.m.
- Award Decisions: Monday, May 6, 2019
- Funding Available: Monday, June 3, 2019
- One-Year Progress Report Due: Monday, May 4,
2020 " Final Report Due: Monday, May 3, 2021
Amount of Funding
Gift awards range from $50,000 up to $200,000 for up to 2 years for
both direct and indirect costs. It may be possible to apply for renewal
with additional funding on subsequent RFP rounds. However, new projects
will be prioritized. This fund does not support incremental research.
Applications must be submitted by Monday, March 11, 2019 at 5 p.m
EST via the Emerson Collective online
submission portal. PLEASE NOTE: The Johns Hopkins institution
code (required for application) is EC7.
Guidelines (up to 4 pages)
A recommended outline includes:
- Title Page (one page): Project title; PI name,
title, department, address, phone, and email address; Co-PI(s) name,
title, department, address, phone, and email address
- Lay abstract/Proposal Overview (½ page)
- Background, Significance and Innovation (½
- Specific Aims (one page)
- Scientific Approach and Methods (2 pages):
Should include an aim overview, preliminary studies, experimental
plan, anticipated results and potential shortcomings. Research proposals
must be single-spaced, with margins of no less than ½ inch
and in Arial or Helvetica font, size 11 or larger.
Other Documents Guidelines
Milestones, References, Illustrations, Biosketch and budget forms.
- References (up to 1 page; REQUIRED)
- Illustrations (no page recommendation; OPTIONAL)
- Milestones/Deliverables (½ page; REQUIRED)
- All PI and Co-PI(s) must include an NIH style
biosketch describing their educational background, positions held,
and key publications (up to 4 pages per investigator).
- Budget form must also be submitted for
each year of funding requested; see template here.
- Funding is available to support personnel,
supplies, equipment, and other general costs associated with the
project. Provide a categorical budget outline for the project,
see budget template for details. A 15% indirect charge applies
to the project costs and should be included in your budget request.
Total budget request including the both direct and indirect costs
should not exceed $200K.
o All proposed budgeting must conform to the general policies
of the institution.
Acceptance or Rejection
This RFP is not an offer to contract. Due to the high volume of applications,
reviewers will be unable to provide feedback on proposals that are not
selected. Acceptance of a proposal neither commits Emerson Collective
to award a contract to any supplier nor limits Emerson Collective's
rights to 1) accept or reject any proposals part or in whole; 2) request
further clarification on any specific response, omission or claim made
in a response to the RFP; 3) to further evaluate one or more proposals
via additional interviews/presentations, or other additional criteria;
and 4) to further negotiate the terms submitted in a proposal, including
price, prior to the final award.
Questions? Please submit questions to Andrew Isaac
in the Office of Foundation Relations (email@example.com;
Ready to submit? Please submit proposals
using the Emerson Collective's online submission portal - (LINK TO BE
PROVIDED AFTER JANUARY 7TH).
Michael J. Fox Foundation (MJFF) Challenge
No application deadline
The Michael J. Fox
Foundation is sponsoring a
$2 million prize to the first team to develop a viable selective
alpha-synuclein PET tracer and agree to make that tracer available broadly.
The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer.
Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry.
- Contestants must apply for the prize with
pre-clinical and clinical data supporting the broad use of their alpha-synuclein
radiotracer. Judges may ask for additional data, including but not
limited to raw imaging data.
- NOTE: All contestants must agree to
make the winning radiotracer available for use by The Michael J. Fox
Foundation and MJFF awardees through a nonexclusive license or other
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use. If no award is given by mid-2018,
The Michael J. Fox Foundation will evaluate the state of the field and
utility of such a prize.
Return to top of Funding Opportunities